Experimental Drug CS18 Shows Promise in Overcoming Therapy-Resistant Tumors, Baylor Researchers Find
Researchers at the Baylor College of Medicine have developed an experimental small-molecule drug known as CS18 that offers a potential new avenue for tackling tumors that have grown resistant to…
Detailed Cellular Maps of Breast Tumors Reveal Guarded "Niches" of Dormant Cancer Cells That Threaten Long-Term Recovery
Researchers have successfully constructed a high-resolution, detailed cellular map of breast tumors, offering an unprecedented look into the internal architecture of cancer. The groundbreaking study, which sheds light on why…